Quanex Building Products earnings release, September 3, 2026

Quanex Building Products CORP (NX) · Form 8-K, Item 2.02 · Filed · SEC filing

Quanex Building Products Announces Third Quarter 2026 Results

Net Sales Growth

Volumes Continue to Track Normal Seasonality Patterns

Margin Expansion Realized in Hardware Solutions Segment and on Consolidated Basis

$42.25 Million of Debt Repaid in 3Q26

Continued Progress and Execution on Working Capital Management

HOUSTON, Sept. 03, 2026 (GLOBE NEWSWIRE) --

Quanex Building Products Corporation

(NYSE:NX) (“Quanex” or the “Company”) today announced its results for the three months ended July 31, 2026.

The Company reported the following selected financial results:

(See Non-GAAP Terminology Definitions and Disclaimers section, Non-GAAP Financial Measure Disclosure table, Selected Segment Data table and reconciliation tables for additional information)

George Wilson, Chairman, President and Chief Executive Officer, stated, “Volumes continued to track normal seasonality patterns during the third quarter of 2026, and we made meaningful progress addressing the price versus cost imbalance that impacted our margins in the second quarter of 2026. Inflationary pressures related to macroeconomic concerns and the ongoing conflict in the Middle East are still having an impact, but the initial rate and magnitude of these pressures have somewhat subsided.

“We stayed focused on managing our working capital during the third quarter of 2026, which when coupled with the seasonal uptick in volumes, enabled us to repay $42.25 million of debt and buy back some of our shares. We will continue to prioritize repaying debt and opportunistically repurchasing our shares as we generate cash in the fourth quarter of 2026. In addition, we will continue to identify operational efficiencies and commercial synergies that we believe will benefit us when consumer confidence and demand improve.”

Third Quarter 2026 Results Summary

Quanex reported net sales of $501.8 million during the three months ended July 31, 2026, which represents an increase of 1.3% compared to $495.3 million for the same period in 2025, mainly due to favorable impacts from pricing, partially offset by the impact of IEEPA tariff reimbursements to customers. The Hardware Solutions segments reported a 2.7% decline in net sales for the third quarter of 2026, driven by lower volumes and the impact of IEEPA tariff reimbursements to customers, which were somewhat offset by favorable impacts from pricing. The Extruded Solutions segments reported net sales growth of 2.8% for the third quarter of 2026, as lower volumes were more than offset by favorable impacts from pricing. Quanex reported an increase of 8.5% in net sales for the third quarter of 2026 in its Custom Solutions segment, largely due to increased volume and improved pricing. (See Sales Analysis table for additional information)

On a consolidated basis, the increase in reported earnings for the third quarter of 2026 compared to the third quarter of 2025 was mainly due to improved pricing, lower depreciation and amortization expense and lower interest expense. Results for the third quarter of 2025 were also impacted by a $302.3 million non-cash goodwill impairment.

Balance Sheet & Liquidity Update

As of July 31, 2026, the Company had total debt of $672.2 million and Quanex’s leverage ratio of Net Debt to LTM Adjusted EBITDA was 2.8x. As of July 31, 2026, Quanex reported LTM Net Income of $45.4 million and LTM Adjusted EBITDA of $215.2 million (See Non-GAAP Terminology Definitions and Disclaimers section, Net Debt Reconciliation table and Last Twelve Months Adjusted EBITDA Reconciliation table for additional information)

The Company’s liquidity increased by 10.5% to $363.1 million as of July 31, 2026, consisting of $62.1 million in cash on hand plus availability under its Senior Secured Revolving Credit Facility due 2029, less letters of credit outstanding.

Share Repurchases

Quanex’s Board authorized a $75 million share repurchase program in December of 2021. Repurchases under this program will be made in open market transactions or privately negotiated transactions, subject to market conditions, applicable legal requirements, and other relevant factors. The Company repurchased 99,786 shares of common stock for approximately $1.7 million at an average price of $17.10 per share during the three months ended July 31, 2026. As of July 31, 2026, approximately $28.7 million remained under the existing share repurchase authorization.

Conference Call and Webcast Information

The Company has scheduled a conference call for Friday, September 4, 2026, at 11:00 a.m. ET (10:00 a.m. CT) to discuss the release. A link to the live audio webcast will be available on Quanex’s website at http://www.quanex.com in the Investors section under Presentations & Events.

Participants can pre-register for the conference call using the following link: https://register-conf.media-server.com/register/BIac7900426be941999342c141e5049229

Registered participants will receive an email containing conference call details for dial-in options. To avoid delays, it is recommended that participants dial into the conference call ten minutes ahead of the scheduled start time. A replay will be available for a limited time on the Company’s website at http://www.quanex.com in the Investors section under Presentations & Events.

About Quanex

Quanex is a global manufacturer with core capabilities and broad applications across various end markets. The Company currently partners with leading OEMs to provide innovative solutions in window, door, solar, refrigeration, custom mixing, building access and cabinetry markets. Looking ahead, Quanex plans to leverage its material science expertise and process engineering to expand into adjacent markets.

Non-GAAP Terminology Definitions and Disclaimers... (truncated)and reorganization costs, restructuring charges related to severance and disposal of software, amortization expense related to intangible assets, pension settlement refund and other net adjustments related to foreign currency transaction gain/loss and effective tax rates reflecting impacts of adjustments on a with and without basis) and Adjusted EPS are non-GAAP financial measures that Quanex believes provide a consistent basis for comparison between periods and more accurately reflect operational performance, as they are not influenced by certain income or expense items not affecting ongoing operations. EBITDA (defined as net income or loss before interest, taxes, depreciation and amortization and other, net), Adjusted EBITDA and LTM Adjusted EBITDA (defined as EBITDA further adjusted to exclude purchase price accounting inventory step-ups, transaction costs, certain severance charges, gain/loss on the sale of certain fixed assets, restructuring charges and asset impairment charges) are non-GAAP financial measures that the Company uses to measure operational performance and assist with financial decision-making. Net Debt is defined as total debt (outstanding balance on the revolving credit facility plus financial lease obligations) less cash and cash equivalents. The leverage ratio of Net Debt to LTM Adjusted EBITDA is a financial measure that the Company believes is useful to investors and financial analysts in evaluating Quanex’s leverage. In addition, with certain limited adjustments, this leverage ratio is the basis for a key covenant in the Company’s credit agreement.

Free Cash Flow is a non-GAAP measure calculated using cash provided by operating activities less capital expenditures. Quanex uses the Free Cash Flow metric to measure operational and cash management performance and assist with financial decision-making. Free Cash Flow is measured before application of certain contractual commitments (including capital lease obligations), and accordingly is not a true measure of the Company’s residual cash flow available for discretionary expenditures. Quanex believes Free Cash Flow is useful to investors in understanding and evaluating the Company’s financial and cash management performance.

Quanex believes that the presented non-GAAP measures provide a consistent basis for comparison between periods and will assist investors in understanding the Company’s financial performance when comparing results to other investment opportunities. These measures allow management and investors to evaluate operational performance and trends without the impact of certain non-cash charges, acquisition-related costs, and other items that may vary significantly from period to period and may not be reflective of Quanex’s core operating results. The presented non-GAAP measures may not be the same as those used by other companies. The Company does not intend for this information to be considered in isolation or as a substitute for other measures prepared in accordance with U.S. GAAP.

Forward Looking Statements

Financial statements

Income Statement

Three Months Ended July 31, — The Company reported the following selected financial results: ($ in millions, except per share data)

Three Months Ended July 31, – 2026Three Months Ended July 31, – 2025Nine Months Ended July 31, – 2026Nine Months Ended July 31, – 2025
Net Sales501.8495.31,373.31,347.8
Gross Margin141.5138357.8361.7
Gross Margin %28.2%27.9%26.1%26.8%
Operating Income (Loss)46.5-270.868.1-236.9
Net Income (Loss)26.5-27625.8-270.4
Diluted EPS0.58-6.040.57-5.83
Adjusted Net Income3631.64768.4
Adjusted Diluted EPS0.790.691.031.47
Adjusted EBITDA72.770.3144.3172
Adjusted EBITDA Margin %14.5%14.2%10.5%12.8%
Cash Provided By Operating Activities58.660.757.376.6
Free Cash Flow47.846.224.235.6

Income Statement (In thousands, except per share data)

Three Months Ended July 31, – 2026Three Months Ended July 31, – 2025Nine Months Ended July 31, – 2026Nine Months Ended July 31, – 2025
Net sales501,845495,2731,373,3011,347,795
Cost of sales360,380357,3051,015,517986,129
Selling, general and administrative70,83771,270216,695208,253
Restructuring charges1,36710,207
Depreciation and amortization24,13833,88273,03777,814
Asset impairment charges302,284302,284
Operating income (loss)46,490-270,83568,052-236,892
Interest expense-11,978-14,218-36,387-42,344
Other, net-938555,9721,925
Income (loss) before income taxes34,419-284,19837,637-277,311
Income tax (expense) benefit-7,9158,191-11,8546,934
Net income (loss)26,504-276,00725,783-270,377
Earnings (loss) per common share, basic0.58-6.040.57-5.83
Earnings (loss) per common share, diluted0.58-6.040.57-5.83
Weighted average common shares outstanding:Basic45,46145,69145,46646,395
Weighted average common shares outstanding:Diluted45,64845,69145,60746,395
Weighted average common shares outstanding:Cash dividends per share0.080.080.240.24

Income Statement (In thousands, except per share data)

Three Months Ended July 31, 2026 – ReconciliationThree Months Ended April 30, 2026 – ReconciliationThree Months Ended January 31, 2026 – ReconciliationThree Months Ended October 31, 2025 – ReconciliationTotal – Reconciliation
Net income (loss) as reported26,5043,350-4,07119,57145,354
Income tax expense (benefit)7,9153,76617315,14727,001
Other, net93-448-5,617-5,246-11,218
Interest expense11,97812,04212,36713,46849,855
Depreciation and amortization24,13824,65024,24925,63098,667
EBITDA70,62843,36027,10168,570209,659
Cost of sales (1)1,2231214073082,059
Selling, general and administrative (1),(2)894688-1262,0403,496
Adjusted EBITDA72,74544,16927,38270,918215,214
(1) Severance and other expenses related to manufacturing footprint and performance optimization.(1) Severance and other expenses related to manufacturing footprint and performance optimization.(1) Severance and other expenses related to manufacturing footprint and performance optimization.(1) Severance and other expenses related to manufacturing footprint and performance optimization.(1) Severance and other expenses related to manufacturing footprint and performance optimization.(1) Severance and other expenses related to manufacturing footprint and performance optimization.
(2) Transaction, advisory fees, severance and reorganization costs.(2) Transaction, advisory fees, severance and reorganization costs.(2) Transaction, advisory fees, severance and reorganization costs.(2) Transaction, advisory fees, severance and reorganization costs.(2) Transaction, advisory fees, severance and reorganization costs.(2) Transaction, advisory fees, severance and reorganization costs.

Income Statement (In thousands, except per share data)

Three Months Ended July 31, 2026 – Net IncomeReconciliationIncome StatementThree Months Ended July 31, 2026 – Diluted EPSReconciling ItemsThree Months Ended July 31, 2025 – Net IncomeReconciliationIncome StatementThree Months Ended July 31, 2025 – Diluted EPSReconciling ItemsNine Months Ended July 31, 2026 – Net IncomeReconciliationIncome StatementNine Months Ended July 31, 2026 – Diluted EPSReconciling ItemsNine Months Ended July 31, 2025 – Net IncomeReconciliationIncome StatementNine Months Ended July 31, 2025 – Diluted EPSReconciling Items
Net income (loss) as reported26,5040.58-276,007-6.0425,7830.57-270,377-5.83
Net income(loss) reconciling items from below9,5070.21307,5786.7321,2210.46338,7567.3
Adjusted net income and adjusted EPS36,0110.7931,5710.6947,0041.0368,3791.47
Reconciliation of Adjusted EBITDAThree Months Ended July 31, 2026Three Months Ended July 31, 2025Nine Months Ended July 31, 2026Nine Months Ended July 31, 2025
Net income (loss) as reported26,504-276,00725,783-270,377
Income tax expense7,915-8,19111,854-6,934
Other, net93-855-5,972-1,925

Income Statement (in thousands)

This table provides gross margin, operating income (loss), EBITDA, and Adjusted EBITDA by reportable segment. Non-operating expense and income tax expense are not allocated to the reportable segments. – Hardware SolutionsThis table provides gross margin, operating income (loss), EBITDA, and Adjusted EBITDA by reportable segment. Non-operating expense and income tax expense are not allocated to the reportable segments. – Extruded SolutionsThis table provides gross margin, operating income (loss), EBITDA, and Adjusted EBITDA by reportable segment. Non-operating expense and income tax expense are not allocated to the reportable segments. – Custom SolutionsThis table provides gross margin, operating income (loss), EBITDA, and Adjusted EBITDA by reportable segment. Non-operating expense and income tax expense are not allocated to the reportable segments. – Unallocated Corp & OtherThis table provides gross margin, operating income (loss), EBITDA, and Adjusted EBITDA by reportable segment. Non-operating expense and income tax expense are not allocated to the reportable segments. – Total
Three months ended July 31, 2026Net sales220,923179,291111,007-9,376501,845
Three months ended July 31, 2026Cost of sales162,056121,38985,861-8,926360,380
Three months ended July 31, 2026Gross Margin58,86757,90225,146-450141,465
Three months ended July 31, 2026Gross Margin %26.6%32.3%22.7%28.2%
Three months ended July 31, 2026Selling, general and administrative (1)33,16222,27913,1432,25370,837
Three months ended July 31, 2026Depreciation and amortization11,3867,2135,33020924,138
Three months ended July 31, 2026Operating (loss) income14,31928,4106,673-2,91246,490
Three months ended July 31, 2026Depreciation and amortization11,3867,2135,33020924,138
Three months ended July 31, 2026EBITDA25,70535,62312,003-2,70370,628
Three months ended July 31, 2026Expense related to plant relocation and closure (Cost of sales)1,2231,223
Three months ended July 31, 2026Reorganization and severance costs1271766894
Three months ended July 31, 2026Adjusted EBITDA27,05535,62412,003-1,93772,745
Three months ended July 31, 2026Adjusted EBITDA Margin %12.2%19.9%10.8%14.5%
Three months ended July 31, 2025Net sales227,116174,427102,264-8,534495,273
Three months ended July 31, 2025Cost of sales170,282116,59777,755-7,329357,305
Three months ended July 31, 2025Gross Margin56,83457,83024,509-1,205137,968
Three months ended July 31, 2025Gross Margin %25.0%33.2%24.0%27.9%
Three months ended July 31, 2025Selling, general and administrative (1)32,95420,74011,7085,86871,270
Three months ended July 31, 2025Restructuring charges1,14034261671,367
Three months ended July 31, 2025Depreciation and amortization16,9876,9894,7165,19033,882
Three months ended July 31, 2025Asset impairment charges163,19854,93484,152302,284
Three months ended July 31, 2025Operating income (loss)-157,445-24,867-76,093-12,430-270,835
Three months ended July 31, 2025Depreciation and amortization16,9876,9894,7165,19033,882
Three months ended July 31, 2025Asset impairment charges163,19854,93484,152302,284
Three months ended July 31, 2025EBITDA22,74037,05612,775-7,24065,331
Three months ended July 31, 2025Expense related to plant relocation and closure (Cost of sales)148148
Three months ended July 31, 2025Transaction, advisory fees, reorganization costs, and product recall expenses715502,6843,449
Three months ended July 31, 2025Restructuring charges1,14034261671,367
Three months ended July 31, 2025Adjusted EBITDA24,74337,09012,851-4,38970,295
Three months ended July 31, 2025Adjusted EBITDA Margin %10.9%21.3%12.6%14.2%
Nine months ended July 31, 2026Net sales613,054484,040304,062-27,8551,373,301
Nine months ended July 31, 2026Cost of sales475,172331,979236,302-27,9361,015,517
Nine months ended July 31, 2026Gross Margin137,882152,06167,76081357,784
Nine months ended July 31, 2026Gross Margin %22.5%31.4%22.3%26.1%
Nine months ended July 31, 2026Selling, general and administrative (1)103,10565,08440,1828,324216,695
Nine months ended July 31, 2026Depreciation and amortization34,62621,89315,95656273,037
Nine months ended July 31, 2026Operating (loss) income15165,08411,622-8,80568,052
Nine months ended July 31, 2026Depreciation and amortization34,62621,89315,95656273,037
Nine months ended July 31, 2026EBITDA34,77786,97727,578-8,243141,089
Nine months ended July 31, 2026Expense related to plant relocation and closure (Cost of sales)1,7511,751
Nine months ended July 31, 2026Credit related to plant relocation (SG&A)-8-8
Nine months ended July 31, 2026Reorganization and severance costs273111,1891,464
Nine months ended July 31, 2026Adjusted EBITDA36,79386,97827,579-7,054144,296
Nine months ended July 31, 2026Adjusted EBITDA Margin %6.0%18.0%9.1%10.5%
Nine months ended July 31, 2025Net sales614,791478,024284,809-29,8291,347,795
Nine months ended July 31, 2025Cost of sales466,600325,914219,755-26,140986,129

Income Statement (in thousands)

Three Months Ended July 31, – 2026Three Months Ended July 31, – 2025Nine Months Ended July 31, – 2026Nine Months Ended July 31, – 2025
Window and door hardware133,038148,303387,047405,497
Screens85,83076,809219,980203,269
Other2,0552,0046,0276,025
220,923227,116613,054614,791
Extruded Solutions:(2)Window profiles75,68476,775206,581206,629
Extruded Solutions:(2)Seals and gaskets20,24120,41557,40557,857
Extruded Solutions:(2)Spacers59,99655,201160,124148,733
Extruded Solutions:(2)Solar5,3755,25015,29217,835
Extruded Solutions:(2)Flashing Tape2,8213,0387,5676,751
Extruded Solutions:(2)Window and door hardware10,07910,67626,06131,311
Extruded Solutions:(2)Other5,0953,07211,0108,908
Extruded Solutions:(2)179,291174,427484,040478,024
Custom Solutions:(3)Wood solutions59,28253,409162,841148,456
Custom Solutions:(3)Access solutions29,48327,37078,98474,158
Custom Solutions:(3)Mixing solutions22,24221,48562,23762,195
Custom Solutions:(3)111,007102,264304,062284,809
Unallocated Corporate & Other:Eliminations-9,376-8,534-27,855-29,829
Unallocated Corporate & Other:)-9,376-8,534-27,855-29,829
Unallocated Corporate & Other:Net Sales501,845495,2731,373,3011,347,795
Unallocated Corporate & Other:(1) Reflects an unfavorable $0.2 million and favorable $6.5 million impact on revenue associated with foreign currency exchange rate impacts for the three and nine months ended July 31, 2026, respectively.(1) Reflects an unfavorable $0.2 million and favorable $6.5 million impact on revenue associated with foreign currency exchange rate impacts for the three and nine months ended July 31, 2026, respectively.(1) Reflects an unfavorable $0.2 million and favorable $6.5 million impact on revenue associated with foreign currency exchange rate impacts for the three and nine months ended July 31, 2026, respectively.(1) Reflects an unfavorable $0.2 million and favorable $6.5 million impact on revenue associated with foreign currency exchange rate impacts for the three and nine months ended July 31, 2026, respectively.(1) Reflects an unfavorable $0.2 million and favorable $6.5 million impact on revenue associated with foreign currency exchange rate impacts for the three and nine months ended July 31, 2026, respectively.

Balance Sheet (in thousands)

July 31, 2026October 31, 2025
Current assets:Cash and cash equivalents62,09476,018
Current assets:Restricted Cash2,1232,100
Current assets:Accounts receivable, net214,768205,384
Current assets:Inventories276,396254,122
Current assets:Income taxes receivable5,603
Current assets:Prepaid assets37,45232,387
Current assets:Other current assets3,8473,764
Current assets:Total current assets602,283573,775
Current assets:Property, plant and equipment, net394,021411,591
Current assets:Operating lease right-of-use assets171,552154,866
Current assets:Deferred tax assets3002,706
Current assets:Goodwill273,765271,346
Current assets:Intangible assets, net522,218549,137
Current assets:Other assets4,5524,812
Current assets:Total assets1,968,6911,968,233
Current liabilities:Accounts payable127,030131,307
Current liabilities:Accrued liabilities88,20995,155
Current liabilities:Income taxes payable9,30012,076
Current liabilities:Current maturities of long-term debt26,55127,561
Current liabilities:Current operating lease liabilities18,82215,446
Current liabilities:Total current liabilities269,912281,545
Current liabilities:Long-term debt636,814665,268
Current liabilities:Noncurrent operating lease liabilities160,290145,459
Deferred pension benefitsDeferred income taxes137,766135,993
Deferred pension benefitsLiabilities for uncertain tax positions1,857
Deferred pension benefitsOther liabilities16,60813,789
Deferred pension benefitsTotal liabilities1,223,2471,242,054
Stockholders’ equity:Common stock512512
Stockholders’ equity:Additional paid-in-capital697,598700,029
Stockholders’ equity:Retained earnings179,472164,710
Stockholders’ equity:Accumulated other comprehensive loss-32,142-35,439
Stockholders’ equity:Treasury stock at cost-99,996-103,633
Stockholders’ equity:Total stockholders’ equity745,444726,179
Stockholders’ equity:Total liabilities and stockholders' equity1,968,6911,968,233

Cash Flow (in thousands)

Nine Months Ended July 31, – 2026Nine Months Ended July 31, – 2025
Operating activities:Net (loss) income25,783-270,377
Adjustments to reconcile net loss to cash used for operating activities:Depreciation and amortization73,03777,814
Adjustments to reconcile net loss to cash used for operating activities:Stock-based compensation3,6172,762
Adjustments to reconcile net loss to cash used for operating activities:Deferred income tax664-26,440
Adjustments to reconcile net loss to cash used for operating activities:Goodwill impairment charge302,284
Adjustments to reconcile net loss to cash used for operating activities:Other, net4,6409,203
Changes in assets and liabilities:Increase in accounts receivable-8,685-1,727
Changes in assets and liabilities:(Increase) decrease in inventory-21,1295,261
Changes in assets and liabilities:Increase in other current assets-4,430-7,228
Changes in assets and liabilities:(Decrease) increase in accounts payable-2,365144
Changes in assets and liabilities:Decrease in accrued liabilities-7,601-9,725
Changes in assets and liabilities:Change in income taxes-6,629-21
Changes in assets and liabilities:Other, net366-5,307
Changes in assets and liabilities:Cash provided by operating activities57,26876,643
Investing activities:Capital expenditures-33,066-40,996
Investing activities:Proceeds from disposition of capital assets62361
Investing activities:Cash used for investing activities-33,004-40,635
Financing activities:Borrowings under credit facilities141,500170,000
Financing activities:Repayments of credit facility borrowings-164,250-213,750
Financing activities:Repayments of other long-term debt-3,316-1,962
Financing activities:Common stock dividends paid-10,916-11,233
Financing activities:Purchase of treasury stock-1,707-29,248
Financing activities:Other, net-704-1,186

Cash Flow (in thousands)

The following table reconciles the Company's calculation of Free Cash Flow, a non-GAAP measure, to its most directly comparable GAAP measure. The Company defines Free Cash Flow as cash provided by operating activities less capital expenditures. – Three Months Ended July 31, – 2026As of July 31, – 2026The following table reconciles the Company's calculation of Free Cash Flow, a non-GAAP measure, to its most directly comparable GAAP measure. The Company defines Free Cash Flow as cash provided by operating activities less capital expenditures. – Three Months Ended July 31, – 2025As of July 31, – 2025The following table reconciles the Company's calculation of Free Cash Flow, a non-GAAP measure, to its most directly comparable GAAP measure. The Company defines Free Cash Flow as cash provided by operating activities less capital expenditures. – Nine Months Ended July 31, – 2026The following table reconciles the Company's calculation of Free Cash Flow, a non-GAAP measure, to its most directly comparable GAAP measure. The Company defines Free Cash Flow as cash provided by operating activities less capital expenditures. – Nine Months Ended July 31, – 2025
Cash provided by operating activities58,55460,65657,26876,643
Capital expenditures-10,744-14,452-33,066-40,996
Free Cash Flow47,81046,20424,20235,647
The following table reconciles the Company's Net Debt which is defined as total debt principal of the Company plus finance lease obligations minus cash.The following table reconciles the Company's Net Debt which is defined as total debt principal of the Company plus finance lease obligations minus cash.The following table reconciles the Company's Net Debt which is defined as total debt principal of the Company plus finance lease obligations minus cash.
Term loan facility450,000475,000
Revolving credit facility168,500197,500
Finance lease obligations (1)53,69761,194
Total debt (2)672,197733,694
Less: Cash and cash equivalents62,09466,272
Net Debt610,103667,422
(1) Includes $47.9 million and $58.9 million in real estate lease liabilities considered finance leases under U.S. GAAP as of July 31, 2026 and 2025, respectively.(1) Includes $47.9 million and $58.9 million in real estate lease liabilities considered finance leases under U.S. GAAP as of July 31, 2026 and 2025, respectively.(1) Includes $47.9 million and $58.9 million in real estate lease liabilities considered finance leases under U.S. GAAP as of July 31, 2026 and 2025, respectively.
(2) Excludes outstanding letters of credit.(2) Excludes outstanding letters of credit.(2) Excludes outstanding letters of credit.
Full release

This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Statements that use the words “estimated,” “expect,” “could,” “should,” “believe,” “will,” “might,” “anticipate,” “intend,” “plan,” “project,” “seek,” “would,” “may,” or similar words reflecting future expectations or beliefs are forward-looking statements. The forward-looking statements include, but are not limited to, the following: Quanex’s future operating results, future financial condition, future uses of cash and other expenditures, expenses and tax rates, expectations relating to the Company’s industry, expectations regarding the recovery of price versus cost imbalances, anticipated debt repayment and share repurchase activity, expected operational efficiencies and synergies and the Company’s future growth, including any guidance discussed in this press release. The statements and guidance set forth in this release are based on current expectations. Actual results or events may differ materially from those expressed or implied in these forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. For a complete discussion of factors that may affect the Company’s future performance, please refer to Quanex’s Annual Report on Form 10-K for the fiscal year ended October 31, 2025, and the Company’s Quarterly Reports on Form 10-Q under the sections entitled “Cautionary Note Regarding Forward-Looking Statements” and “Risk Factors”. Any forward-looking statements in this press release are made as of the date hereof, and the Company undertakes no obligation to update or revise any forward-looking statements, whether written or oral, to reflect new information, developments or events.

Earlier releases

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.